Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

212
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
01/20/2015 01/21/2015 01/22/2015 01/23/2015 01/26/2015 Date
88.85(c) 84.75(c) 84.3(c) 85.5(c) 87(c) Last
9 948 938 13 741 778 10 406 047 9 570 672 8 251 592 Volume
+0.91% -4.61% -0.53% +1.42% +1.75% Change
More quotes
Company
Novartis AG develops, manufactures, and markets healthcare products.It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, Vaccines and Diagnostics, and Consumer Health.The Pharmaceuticals segment provides patent-protected prescription medicines.The Alcon segment offers... 
Sector
Pharmaceuticals
Calendar
01/27Earnings Release
More about the company
Surperformance© ratings of Novartis AG
Trading Rating : Investor Rating :
More Ratings
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 58 079 M
EBIT 2014 14 417 M
Net income 2014 10 787 M
Debt 2014 4 793 M
Yield 2014 2,83%
Sales 2015 55 859 M
EBIT 2015 14 877 M
Net income 2015 11 201 M
Debt 2015 8 116 M
Yield 2015 2,97%
PER 2014 21,86
PER 2015 20,33
EV / Sales 2014 4,69x
EV / Sales 2015 4,93x
Capitalization 267 453 M
More Financials
Latest news on NOVARTIS AG
04:57aDJEUROPE MARKETS : Philips, Siemens Shares Weigh On European Markets
04:13a Novartis flags faster sales and profit growth for 2015
03:39a NOVARTIS : Swiss drug maker Novartis posts Q4 profit drop
03:02aDJNovartis Upbeat Despite Weaker Profit -- Update
01:41aDJNOVARTIS : Posts Fall in Fourth-Quarter Profit
01:02a NOVARTIS : delivered solid sales growth, margin expansion and pipeline progress ..
01/26 NOVARTIS : Alcon - Novartis National Sales Meeting Successfully Held at PEACH
01/26 NOVARTIS : Bexsero vaccine approved by FDA for the prevention of meningitis B, t..
More news
Sector news Pharmaceuticals - NEC
05:04a Baiyunshan, Siemens to March into Medical Devices
04:13a Novartis flags faster sales and profit growth for 2015
03:21aDJRichter Signs License, Distribution Deal with Bayer HealthCare
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF